Morning Analyst Calls Briefing for Monday, November 21, 2022 

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Morning Analyst Calls Briefing for Monday, November 21, 2022 

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Canadian Natrl Res (CNQ) upgraded to Buy from Neutral at Goldman; tgt raised to $69

> Mueller Water (MWA) upgraded to Buy from Neutral at Northcoast

> On (ONON) upgraded to Buy from Neutral at Goldman; tgt lowered to $28

> Walt Disney (DIS) upgraded to Outperform from Market Perform at MoffettNathanson; tgt $120

Downgrades:

> American Homes 4 Rent (AMH) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $33

> Aveanna (AVAH) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $3

> Cenovus Energy (CVE) downgraded to Neutral from Buy at Goldman; tgt $23

> Cigna (CI) downgraded to Outperform from Strong Buy at Raymond James; tgt $370

> ConocoPhillips (COP) downgraded to Sell from Hold at Societe Generale; tgt $114

> EverCommerce (EVCM) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $9

> Extra Space Storage (EXR) downgraded to Underperform from In-line at Evercore ISI; tgt lowered to $150

> Federal Signal (FSS) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets

> Four Corners Property Trust (FCPT) downgraded to In-line from Outperform at Evercore ISI; tgt $28

> Kimco Realty (KIM) downgraded to In-line from Outperform at Evercore ISI; tgt $22

> MongoDB (MDB) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $215

Others:

> Affiliated Managers (AMG) resumed with a Buy at Goldman; tgt $182

> Apollo Commercial Real Estate (ARI) resumed with a Neutral at BofA Securities; tgt $12

> Cue Biopharma (CUE) initiated with an Overweight at Piper Sandler; tgt $7

> ImmunoGen (IMGN) initiated with a Buy at Truist; tgt $10

> Mersana Therapeutics (MRSN) initiated with a Buy at Truist; tgt $12

> Mobileye Global (MBLY) initiated with a Buy at Citigroup; tgt $77

> Mobileye Global (MBLY) initiated with a Buy at Goldman; tgt $36

> Mobileye Global (MBLY) initiated with a Buy at Mizuho; tgt $35

> Mobileye Global (MBLY) initiated with a Buy at Needham; tgt $40

> Mobileye Global (MBLY) initiated with a Neutral at BofA Securities; tgt $34

> Mobileye Global (MBLY) initiated with a Peer Perform at Wolfe Research

> Mobileye Global (MBLY) initiated with a Strong Buy at Raymond James; tgt $50

> Mobileye Global (MBLY) initiated with an Outperform at Cowen; tgt $35

> Mobileye Global (MBLY) initiated with an Outperform at RBC Capital Mkts; tgt $41

> MongoDB (MDB) initiated with an Overweight at KeyBanc Capital Markets; tgt $215

Research calls posted earlier this morning are available here.  

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618